ClinicalTrials.Veeva

Menu
U

Ukrainian Center of Tomotherapy LLC | Kropyvnytskyi, Ukraine

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Pembrolizumab
/Pembrolizumab
Calderasib
MK-1084
Sacituzumab
MK-3475A±MK-1084
Durvalumab
Platinum

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 5 total trials

A Clinical Trial of Calderasib (MK-1084) and Durvalumab in People With Non-Small Cell Lung Cancer (MK-1084-015/KANDLELIT-015)

Researchers are looking for new ways to treat locally advanced non-small cell lung cancer (NSCLC) that is unresected and has a gene mutation called K...

Enrolling
Non-small Cell Lung Cancer
Drug: Calderasib
Biological: Durvalumab

Researchers want to know if sacituzumab tirumotecan given alone or with pembrolizumab can treat triple negative breast cancer (TNBC). The main goal o...

Enrolling
Triple Negative Breast Neoplasms
Biological: Pembrolizumab
Drug: Paclitaxel

This is a phase 3, randomized, double-blind study of adjuvant calderasib plus subcutaneous pembrolizumab and berahyaluronidase alfa (MK-3475A) versus...

Enrolling
Non-small Cell Lung Cancer
Drug: Calderasib
Drug: Placebo

The purpose of this study is to evaluate pembrolizumab (MK-3475) subcutaneous (SC) administration as the first-line therapy in the treatment of metas...

Active, not recruiting
Non-Small Cell Lung Cancer
Drug: Cisplatin
Biological: Pembrolizumab IV

Trial sponsors

Merck Sharp & Dohme (MSD) logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems